195 related articles for article (PubMed ID: 31073843)
1. BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates.
Zak P; Vejrazkova E; Zavrelova A; Pliskova L; Ryskova L; Hubacek P; Stepanova V; Kostal M; Koblizek V; Paterova P; Radocha J
Folia Microbiol (Praha); 2020 Feb; 65(1):109-120. PubMed ID: 31073843
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
4. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
Svensson T; Lundström KL; Höglund M; Cherif H
Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
[TBL] [Abstract][Full Text] [Related]
5. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.
Dellière S; Amar Y; Hamane S; Aissaoui N; Denis B; Bergeron A; Tazi A; Alanio A
Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37996394
[TBL] [Abstract][Full Text] [Related]
6. Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests.
Orsi CF; Bettua C; Pini P; Venturelli C; La Regina A; Morace G; Luppi M; Forghieri F; Bigliardi S; Luppi F; Codeluppi M; Girardis M; Blasi E
New Microbiol; 2015 Jan; 38(1):75-84. PubMed ID: 25742150
[TBL] [Abstract][Full Text] [Related]
7. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
8. Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL.
Boersma WG; Erjavec Z; van der Werf TS; de Vries-Hosper HG; Gouw AS; Manson WL
Respir Med; 2007 Feb; 101(2):317-25. PubMed ID: 16774815
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
Heldt S; Prattes J; Eigl S; Spiess B; Flick H; Rabensteiner J; Johnson G; Prüller F; Wölfler A; Niedrist T; Boch T; Neumeister P; Strohmaier H; Krause R; Buchheidt D; Hoenigl M
J Infect; 2018 Sep; 77(3):235-241. PubMed ID: 29972764
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia.
Oren I; Hardak E; Finkelstein R; Yigla M; Sprecher H
Am J Med Sci; 2011 Sep; 342(3):182-5. PubMed ID: 21642823
[TBL] [Abstract][Full Text] [Related]
12. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
13. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Toluidine Blue O staining for the diagnosis of Pneumocystis jiroveci in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia.
Aderaye G; Woldeamanuel Y; Asrat D; Lebbad M; Beser J; Worku A; Fernandez V; Lindquist L
Infection; 2008 Jun; 36(3):237-43. PubMed ID: 18483698
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
[TBL] [Abstract][Full Text] [Related]
17. Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
Saito T; Shime N; Itoh K; Fujita N; Saito Y; Shinozaki M; Shibuya K; Makimura K; Hashimoto S
Infection; 2009 Dec; 37(6):547-50. PubMed ID: 19730788
[TBL] [Abstract][Full Text] [Related]
18. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
[TBL] [Abstract][Full Text] [Related]
19. [The Pneumocystis jirovecii colonization in bronchoalveolar lavage (BAL) and bronchial washing and the comparison of methods which are used in diagnosis].
Özmen A; Mıstık R; Alver O; Coşkun F; Ursavaş A; Uzaslan E
Tuberk Toraks; 2013; 61(4):303-11. PubMed ID: 24506746
[TBL] [Abstract][Full Text] [Related]
20. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
